As of 2026-06-18, the Fair Value of Cardlytics Inc (CDLX) is -74.30 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.99 USD, the upside of Cardlytics Inc is -1,589.01%.
With the market price of 4.99 USD and our fair value calculation, Cardlytics Inc (CDLX) is not a good investment. Investing in Cardlytics stocks now will result in a potential loss of 1,589.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -128.60 | -465.30 | -134.70 | -189.30 | -103.49 | -204.28 |
| YoY growth | -132.13% | -261.82% | 71.05% | -40.54% | 45.33% | -63.62% |
| Market Cap (mil) | 31.80 |
| P/E | |
| Forward P/E |
| EPS | -14.86 |
| Avg earnings growth rate | -63.62% |
| TTM earnings | -94.69 |